(12-Bromo-dodecyloxy)-tert-butyl-dimethyl-silane

Catalog No.: 
ACSOHK793
CAS No.: 
134413-60-8
Molecular Formula: 
C18H39BrOSi
Molecular Weight: 
379.50
(12-Bromo-dodecyloxy)-tert-butyl-dimethyl-silane structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$621.00InquiryInquiry
5g95%$1862.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(12-Bromo-dodecyloxy)-tert-butyl-dimethyl-silane
IUPAC Name((12-bromododecyl)oxy)(tert-butyl)dimethylsilane
MDL No.MFCD31561453
Molecular FormulaC18H39BrOSi
Molecular Weight379.50
SMILESC[Si](C(C)(C)C)(OCCCCCCCCCCCCBr)C
InChI KeyNFUQZVUAJDEGGF-UHFFFAOYSA-N
Synonym(12-Bromododecyloxy)-tert-butyldimethylsilane;Silane, [(12-bromododecyl)oxy](1,1-dimethylethyl)dimethyl-
CAS No.134413-60-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACSOHK793 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACDOXH089 route compound structure diagram
    ACDOXH0893344-77-2In Stock
  4. Then
  5. ACSOHK793 route product structure diagram
    ACSOHK793134413-60-8
Inquiry

2. ACSOHK793 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDOXH089 route compound structure diagram
    ACDOXH0893344-77-2In Stock
  2. Then
  3. ACSOHK793 route product structure diagram
    ACSOHK793134413-60-8
Inquiry

3. ACSOHK793 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSOHK793 route product structure diagram
    ACSOHK793134413-60-8
Inquiry

Comments (0)